Corcept Therapeutics director's trust sells 10,000 shares

The trust sales were reported under a Rule 10b5-1 plan adopted by director James N. Wilson on March 12, 2026.

Rhea-AI Filing Summary

Corcept Therapeutics Inc. (CORT) director James N. Wilson reported that the James N. Wilson and Pamela D. Wilson Trust sold 10,000 common shares on October 15, 2026: 6,654 shares at a weighted average price of $114.4751 per share, 3,046 at $115.3895, and 300 at $116.2967. The sales were made under a Rule 10b5-1 plan adopted by Wilson on March 12, 2026.

Wilson has voting power over shares held by the selling trust and disclaims beneficial ownership except to the extent of his pecuniary interest. Separate indirect holding entries list 200,000 shares in each of the James N. Wilson 2025 Grantor Retained Annuity Trust and Pamela D. Wilson 2025 Grantor Retained Annuity Trust.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares

Net Sell 5 txns

Insider WILSON JAMES N

Role Director

Sold 10,000 shs ($1.15M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2, F5	6,654	$114.4751	$762K
Sale	Common Stock F1, F3, F5	3,046	$115.3895	$351K
Sale	Common Stock F1, F4, F5	300	$116.2967	$35K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,054,543 shares (Indirect, James N. Wilson and Pamela D. Wilson Trust); Common Stock — 200,000 shares (Indirect, James N. Wilson 2025 Grantor Retained Annuity Trust); Common Stock — 200,000 shares (Indirect, Pamela D. Wilson 2025 Grantor Retained Annuity Trust)

Footnotes (5)

1. F1. This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction.
2. F2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.13 to $115.12 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
3. F3. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.16 to $116.10 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
4. F4. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.19 to $116.35 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
5. F5. Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

Key Figures

Shares sold: 6,654 shares Weighted average sale price: $114.4751 per share Shares sold: 3,046 shares +3 more

6 metrics

Shares sold 6,654 shares October 15, 2026; weighted average sale price was $114.4751 per share

Weighted average sale price $114.4751 per share 6,654 shares sold on October 15, 2026

Shares sold 3,046 shares October 15, 2026; weighted average sale price was $115.3895 per share

Weighted average sale price $115.3895 per share 3,046 shares sold on October 15, 2026

Shares sold 300 shares October 15, 2026; weighted average sale price was $116.2967 per share

Weighted average sale price $116.2967 per share 300 shares sold on October 15, 2026

Key Terms

Rule 10b5-1 plan, weighted average sale price, beneficial ownership, pecuniary interest

4 terms

Rule 10b5-1 plan regulatory

"made pursuant to a 10b5-1 plan adopted by the Reporting Person"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted average sale price financial

"Represents the weighted average sale price for the entire number of shares sold"

beneficial ownership regulatory

"disclaims beneficial ownership of all of such shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest regulatory

"except to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CORT shares did the Wilson trust sell?

The James N. Wilson and Pamela D. Wilson Trust sold 10,000 shares on October 15, 2026, in three reported transactions: 6,654 shares at a weighted average price of $114.4751 per share, 3,046 at $115.3895, and 300 at $116.2967.

What actual price ranges were reported for the CORT share sales?

The actual sale prices ranged from $114.13 to $115.12 for the 6,654-share transaction, from $115.16 to $116.10 for the 3,046-share transaction, and from $116.19 to $116.35 for the 300-share transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/16/2026 - 06:25 PM EDT Accepted by SEC EDGAR 10/16/2026 - 06:24 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILSON JAMES N

(Last) (First) (Middle)

C/O CORCEPT THERAPEUTICS INCORPORATED

101 REDWOOD SHORES PARKWAY

(Street)

REDWOOD CITY CALIFORNIA 94065

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CORCEPT THERAPEUTICS INC [ CORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2026		S(1)		6,654	D	$114.4751(2)	1,057,889	I	James N. Wilson and Pamela D. Wilson Trust(5)
Common Stock	10/15/2026		S(1)		3,046	D	$115.3895(3)	1,054,843	I	James N. Wilson and Pamela D. Wilson Trust(5)
Common Stock	10/15/2026		S(1)		300	D	$116.2967(4)	1,054,543	I	James N. Wilson and Pamela D. Wilson Trust(5)
Common Stock								200,000	I	James N. Wilson 2025 Grantor Retained Annuity Trust
Common Stock								200,000	I	Pamela D. Wilson 2025 Grantor Retained Annuity Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction.

2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.13 to $115.12 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

3. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.16 to $116.10 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

4. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.19 to $116.35 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

5. Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.

	/s/ Joseph Douglas Lyon, as attorney-in-fact for James N. Wilson	10/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)